Work

Gestational diabetes and stillbirth: a systematic review and meta-analysis

Year: 2026

Type: review

Study designs: Systematic Review, Meta-Analysis

Abstract: Background Globally, around 2 million pregnancies each year end in stillbirth, with the majority occurring in low and middle-income countries. The association between gestational diabetes mellitus (GDM) and stillbirth has been widely researched but the evidence is increasingly controversial. The aim of this study is to evaluate the risk of stillbirth associated with GDM, and examine whether this risk differs according to country income status and GDM screening method. Methods We searched Scopus, Cinahl, Cochrane Central, ISRCTN, Medline, Embase and Epistemonikos on the 9th May 2025 from inception to May 2025 with no restrictions based on language, study location or time. We included cohort studies that estimated the association of interest. We conducted a random effects meta-analysis by study design and sub-group analyses by country income level and GDM screening method. (PROSPERO CRD4201800057). Findings 101 included studies (92,915,856 women) presented unadjusted results, 19 reported adjusted results (63,629,536 women). Meta-analysis of adjusted cohort data did not show evidence of an association between a diagnosis of GDM and the risk of stillbirth worldwide (OR 0.81, 95% CI: 0.68–0.97; I 2 = 87.7%; n=19 studies). However, when stratified by country income level a diagnosis of GDM was associated with a reduction in the odds of stillbirth in high income countries (OR 0.73, 95% CI: 0.65–0.82; I 2 = 31.9%; n=13 studies), but this was not observed in upper and lower middle income countries, (OR 1.17, 95% CI: 0.71–1.93; I 2 = 59.7%; n=6 studies). There were no adjusted estimates from low-income countries. There was no evidence of a difference by GDM screening method. Interpretation Increased screening, timely diagnosis and effective management strategies for GDM in high-income countries, such as induction of labour and increased antenatal care, may be responsible for the reduced risk of stillbirth in women with GDM. Further research is needed to identify the optimum strategy for screening and management in low and middle-income settings to reduce preventable stillbirths worldwide. Funding None.

Source: EClinicalMedicine

DOI: 10.1016/j.eclinm.2025.103751